Royal Philips has reported a net profit of 897 million euros for 2025, marking its first profitable year since 2021. The health technology giant has successfully moved past the most difficult phase of the Respironics sleep apnoea recall, which had previously caused heavy losses. This recovery was driven by a rebound in consumer sales, a surge in US medical equipment orders, and a disciplined 2.5 billion euro productivity programme.
Despite American import tariffs, annual turnover rose to 17.8 billion euros. The Personal Health division, known for products such as electric toothbrushes and shavers, led growth, with a 14% sales increase in the final quarter.
Strategic expansion and AI integration
A major highlight of the year was a five-year strategic partnership with AdventHealth, a massive non-profit healthcare system in the US. This collaboration involves replacing and upgrading patient monitoring systems across more than 50 hospital campuses.
To support these large-scale partnerships, Philips is placing artificial intelligence at the heart of its clinical strategy. CEO Roy Jakobs explained the vision:
“In 2025, we delivered on our commitments as we scaled better care for more people. Our unique platform-based innovations in healthcare and self-care provide Philips with a strong growth foundation in a world where data and AI are rapidly transforming care.”
The company is integrating AI into its medical software to automate workflows and support clinical decisions, reducing administrative burdens on staff while improving diagnostic accuracy.
Efficiency at a cost
The return to profit has been accompanied by radical internal changes. Over the past year, Philips restructured its finance and IT departments, leading to job cuts at several sites, including the medical campus in Best. Since 2023, the company has reduced its global workforce by over 13,000 roles to create a “simpler, leaner, and faster” organisation.
However, the restructuring is set to continue. As part of its new 2026–2028 financial targets, Philips plans to achieve an additional 1.5 billion euros in productivity savings. This new phase of “disciplined execution” suggests that further departmental reorganisations are likely as the company shifts toward a decentralised model. By continuing to streamline its operations, Philips aims to achieve mid-teens profit margins by 2028.
While the company has successfully navigated its recent slump, ongoing internal shifts remain central to its strategy to deliver long-term value in an uncertain global economy.
NEWS BRAINPORT
